The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $3.13

Today's change0.00 0.00%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

ImmunoGen Inc

Nasdaq: IMGN
Last

(U.S.) $3.13

Today's change0.00 0.00%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.

ImmunoGen Inc closed at (U.S.)$3.13.

Over the last five days, shares have lost 5.72% and are down 76.93% for the last year to date. This security has underperformed the S&P 500 by 74.72% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $3.13
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-76.93%
  • Volume0
  • Average volume (10-day)5,654,172
  • Average volume (1-month)3,046,278
  • Average volume (3-month)1,733,305
  • 52-week range(U.S.) $3.16 to (U.S.) $19.43
  • Beta1.89
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$1.49
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue20181513
Total other revenue--------
Total revenue20181513
Gross profit--------
Total cost of revenue--------
Total operating expense47464338
Selling / general / administrative11887
Research & development36383530
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-28-28-29-25
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-32-33-34-30
Income after tax-32-33-34-30
Income tax, total--------
Net income-32-33-34-30
Total adjustments to net income--------
Net income before extra. items-32-33-34-30
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-32-33-34-30
Inc. avail. to common incl. extra. items-32-33-34-30
Diluted net income-32-33-34-30
Dilution adjustment--------
Diluted weighted average shares87878786
Diluted EPS excluding extraordinary itemsvalue per share-0.37-0.38-0.39-0.35
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.37-0.38-0.39-0.35